Financhill
Sell
43

APDN Quote, Financials, Valuation and Earnings

Last price:
$0.22
Seasonality move :
1.72%
Day range:
$0.22 - $0.25
52-week range:
$0.12 - $14.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
1.30x
Volume:
4.3M
Avg. volume:
8.6M
1-year change:
-98.16%
Market cap:
$11.9M
Revenue:
$3.4M
EPS (TTM):
-$6.96

Earnings Data

Next earnings date for APDN
Feb 07
2025
Most recent earnings per share
-$0.32
Beat by $0.03
(Dec 17/2024)
Consensus Estimate
-$0.35
(Dec 17/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

APDN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $1.3M -- -- -$0.33 --
02/07/2025 Q4 $1.2M -- -- -$0.33 --
12/17/2024 Q3 $899K $813.1K -$0.32 -$0.35 $0.03
08/08/2024 Q2 $1.1M $797.5K $0.47 -$0.35 $0.82
05/10/2024 Q1 $951K $929.6K -$5.31 -$4.40 -$0.91
02/08/2024 Q4 $776K $891.2K -$1.80 -$6.20 $4.40
09/30/2023 Q3 $1.7M $779.7K -$5.36 -$5.30 -$0.06
08/11/2023 Q2 $2.6M $2.9M -$4.80 -$4.80 --
05/12/2023 Q1 $4.1M $4.4M $0.91 -$4.00 $4.91
02/10/2023 Q4 $4.2M $5.3M -$6.00 -$5.80 -$0.20
12/09/2022 Q3 -- $3.6M $0.20 -- --
08/11/2022 Q2 -- $4.3M -$2.60 -- --
05/13/2022 Q1 -- $6.1M -$4.60 -- --
02/10/2022 Q4 -- $4.2M -$12.60 -- --
12/09/2021 Q3 -- $3M -$12.40 -- --
08/12/2021 Q2 -- $1.7M -$9.60 -- --
05/13/2021 Q1 -- $2.7M -$4.20 -- --
02/11/2021 Q4 -- $1.6M -$17.60 -- --
12/17/2020 Q3 -- $314K -$15.60 -- --
08/06/2020 Q2 -- $431.5K -$14.40 -- --
05/14/2020 Q1 -- $552.5K -$15.80 -- --
02/06/2020 Q4 -- $633.5K -$22.40 -- --
12/12/2019 Q3 -- $1.7M -$24.60 -- --
08/13/2019 Q2 -- $2.1M -$31.00 -- --
05/09/2019 Q1 -- $778.5K -$64.40 -- --
02/07/2019 Q4 -- $884.3K -$85.00 -- --
12/18/2018 Q3 -- $1.2M -$93.20 -- --
08/13/2018 Q2 -- $1M -$80.00 -- --
05/03/2018 Q1 -- $1M -$56.00 -- --
02/08/2018 Q4 -- $647.7K -$96.00 -- --
12/28/2017 Q3 -- $1.1M -$80.00 -- --
08/10/2017 Q2 -- $1.8M -$80.00 -- --
05/11/2017 Q1 -- $905.4K -$104.00 -- --
02/09/2017 Q4 -- $903K -$128.00 -- --
12/06/2016 Q3 -- $1.6M -$80.00 -- --
08/11/2016 Q2 -- $652.9K -$112.00 -- --
05/12/2016 Q1 -- $573.3K -$112.00 -- --
12/31/2015 Q4 -- $1.3M -$104.00 -- --
09/30/2015 Q3 -- $4M -$16.00 -- --
06/30/2015 Q2 -- $2.3M -$64.00 -- --
03/31/2015 Q1 -- $1.5M -$88.00 -- --

Applied DNA Sciences Earnings Questions

  • How Much did Applied DNA Sciences Generate in Revenue Last Quarter?

    Applied DNA Sciences reported $813.1K worth of top line sales in its most recent quarter.

  • Did Applied DNA Sciences Beat Earnings Last Quarter?

    Applied DNA Sciences announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.35 per share.

  • Is Applied DNA Sciences Profitable?

    Applied DNA Sciences reported $244.9K that represents $0.02 per share over the last quarter.

  • What is the Analyst Consensus for Applied DNA Sciences EPS Next Year?

    Applied DNA Sciences's earnings are forecast to decrease from -$1.82 per share to -$1.22 per share next year representing a decrease of -11.9%.

  • When is Applied DNA Sciences's Earnings Date?

    Applied DNA Sciences's next earnings date is February 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 125x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 22.25% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 20.59% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 19.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock